Aripiprazole
Abstract
The Formulary Management Expert Committee (FMEC) recommends that oral aripiprazole be reimbursed as an adjunct to antidepressants for the treatment of major depressive disorder (MDD) in adult patients who have an inadequate response to at least 1 prior antidepressant treatment. The committee determined that there are no conditions necessary for the reimbursement recommendation.
Fields of Study & Subjects
Treatment of Major Depression
Health Systems
Economic Evaluations
Quality of Life
Mental Health Treatment and Access
Publication details
- Journal / source
- Canadian Journal of Health Technologies
- Volume
- 6
- Issue
- 1
- Publication date
- 27 January 2026